News

Latest

The Environmental Protection Agency March 14 issued a final rule that will require significantly reduced emissions from commercial facilities that sterilize medical devices and other equipment using ethylene oxide gas.
The Department of Health and Human Services’ Office for Civil Rights is initiating an investigation into the Change Healthcare cyberattack, the agency announced March 13in a “Dear Colleague” letter.
In anticipation of the first Health Workforce Well-Being Day March 18, the National Academy of Medicine this week held an event to share success stories and resources to inspire action.
Carolyn Isabelle, director of workforce development at Dartmouth Health, discusses the health system's numerous approaches to recruitment and strategies that support a healthy and engaged workforce.
The AHA and other founding members of the Common Health Coalition March 13 committed to action in four priority areas: coordination between health care and public health; always-on emergency preparedness; real-time disease detection; and exchange of actionable data, particularly to advance equity.
The House Energy and Commerce Committee March 12 passed AHA-supported  legislation to reauthorize through 2029 the Dr. Lorna Breen Health Care Provider Protection Act (H.R. 7153), which provides grants to help health care organizations offer behavioral health services for front-line health care workers.
Congress should consider any statutory limitations that exist for an adequate response from the Centers for Medicare & Medicaid Services and Department of Health and Human Services to help hospitals and other providers minimize further fallout from the Change Healthcare cyberattack, AHA wrote March 13 in a letter to Senate Finance Committee leaders.
Sixteen hospitals and health systems have partnered with Microsoft to form the Trustworthy & Responsible AI Network (TRAIN), which aims to operationalize principles to improve the quality, safety and trustworthiness of artificial intelligence in health.
AHA March 12 released a new report from Healthsperien on discounts to 340B hospitals through the 340B Drug Pricing Program relative to drug company revenues and revenue growth.
The U.S. Court of Appeals for the 8th Circuit March 12 upheld Arkansas’ 340B Drug Pricing Nondiscrimination Act against a constitutional challenge brought by the Pharmaceutical Research and Manufacturers of America, ruling that the Federal Food, Drug, and Cosmetic Act does not preempt the state law.